Evidence map›Paper›PMID 25121740›Full record

ArticleCell host & microbe2014

Microbial-derived butyrate: an oncometabolite or tumor-suppressive metabolite?

Scott J Bultman, Christian Jobin

Abstract readComment
In one paragraph

Article in Cell host & microbe, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Gut microbiota in health and disease.Molecular biomedicine · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Advances in the study of the relationship betweenFrontiers in cell and developmental biology · 2025
    Review
  10. Article
  11. Article
  12. Review
  13. The microbial landscape of colorectal cancer.Nature reviews. Microbiology · 2024
    Review
  14. Article
  15. Review
  16. Review
  17. Breast cancers as ecosystems: a metabolic perspective.Cellular and molecular life sciences : CMLS · 2023
    Review
  18. Immuno-oncology-microbiome axis of gastrointestinal malignancy.World journal of gastrointestinal oncology · 2023
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Scott J BultmanDepartment of Genetics and Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC 27516, USA. Electronic address: scott_bultman@med.unc.edu.
Christian JobinDepartment of Infectious Diseases & Pathology, Department of Medicine, University of Florida, Gainesville, FL 32611, USA. Electronic address: christian.jobin@medicine.ufl.edu.

Funding

UNC-CH CENTER FOR ENVIRONMENTAL HEALTH &SUSCEPTIBILITYP30ES010126 · NIEHS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Stephanie Engel · 2001 to 2026
$36.3M
The role of klebsiella pneumonia-derived colibactin in colitis-associated colon cancerR01DK073338 · NIDDK · UNIV OF NORTH CAROLINA CHAPEL HILL · PI JOBIN, CHRISTIAN · 2007 to 2023
$5.4M
NIDDK NIH HHS R01 DK073338NIEHS NIH HHS P30 ES010126
6 · The paper itself

Abstract

Dietary factors, microbial composition, and metabolism are intimately intertwined into a complex network whose activities influence important intestinal functions. In a recent issue of Cell, Belcheva et al. (2014) show that microbial-derived butyrate promotes proliferation of cancer-initiated intestinal epithelial cells, suggesting that it can act as an oncometabolite.

Indexed as

AnimalsColorectal NeoplasmsDietary CarbohydratesMutS Homolog 2 ProteinDietary CarbohydratesMutS Homolog 2 Protein

Identifiers

PMID25121740
PMCPMC4179296

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.